Oncogenesis is associated with intestinal dysbiosis, and stool shotgun metagenomic
sequencing in individuals with this condition might constitute a non-invasive approach for …

The link between drug-induced dysbiosis and its influence on brain diseases through gut-
residing bacteria and their metabolites, named the microbiota-gut-brain axis (MGBA) …

Background & Aims Proton pump inhibitors (PPIs) have a major impact on gut microbiome
and immune function, which in turn, may increase the risk of inflammatory bowel disease …

Deregulations in gut microbiota may play a role in vascular and bone disease in chronic
kidney disease (CKD). As glomerular filtration rate declines, the colon becomes more …

Background/Aim: This study aimed to clarify the impact of proton pump inhibitors (PPIs) on
oncological outcomes in patients who received pembrolizumab for advanced urothelial …

Mounting evidence has linked changes in human gut microbiota to proton pump inhibitor
(PPI) use. Accordingly, multiple studies have analyzed the gut microbiomes of PPI users, but …

Introduction Studies suggest associations between proton pump inhibitors (PPIs) and
dementia risk; however, many neither considered histamine‐2 receptor antagonists (H2RAs) …

Objectives We clarified the effect of concomitant proton pump inhibitor use on oncological
outcomes in patients with advanced urothelial carcinoma treated either with chemotherapy …

Abstract Background Extraintestinal Manifestations (EIMs) are a common and potentially
debilitating complication of Inflammatory Bowel Diseases (IBD), sometimes requiring …

Background Use of acid‐suppressive medications (ASMs), for example, proton pump
inhibitors (PPIs) and histamine‐2 receptor antagonists (H2RAs), has been rising along with …